MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has ...

At least 24 termination letters have been sent out, according to one official. Several active research grants related to studies involving LGBTQ+ issues, gender identity and diversity, equity and ...

Super added that the termination letters are also “unlawful” because the NIH is imposing conditions on funding that did not exist at the time the grants were awarded. The NIH did not respond ...

Mar. 10, 2025 — Researchers have conducted a study that scours 'the vast and often contradictory literature on the carcinogenicity of red and white wine' to assess whether this assumption holds ...

Principal is the amount you borrowed, and interest is the amount you pay to the lender as a charge for borrowing. To calculate interest, multiply the principal amount by the interest rate, then ...

NSAIDs are among the most common pain relievers in the world. And lately, they're among the most controversial. Find out what these anti-inflammatory pills actually do inside your body. NSAIDs ...

A series where we find out which products the professionals (who really know what they’re talking about) actually use and really stand behind. Read more here. Body lotion benefits your legs ...

Background There is a lack of knowledge about the pattern of symptom reporting in the general population as most research focuses on specific diseases or symptoms. The number of musculoskeletal ...

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking ...

Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over TA1044 26 February 2025 26 February 2025 Durvalumab with etoposide and either carboplatin or cisplatin for ...